FOLD
Price
$8.04
Change
-$0.07 (-0.86%)
Updated
Oct 17 closing price
Capitalization
2.48B
18 days until earnings call
Intraday Buy/Sell Signals
PCVX
Price
$42.39
Change
-$1.20 (-2.75%)
Updated
Oct 17 closing price
Capitalization
5.5B
23 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

FOLD vs PCVX

Header iconFOLD vs PCVX Comparison
Open Charts FOLD vs PCVXBanner chart's image
Amicus Therapeutics
Price$8.04
Change-$0.07 (-0.86%)
Volume$3.12M
Capitalization2.48B
Vaxcyte
Price$42.39
Change-$1.20 (-2.75%)
Volume$1.44M
Capitalization5.5B
FOLD vs PCVX Comparison Chart in %
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FOLD vs. PCVX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Hold and PCVX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (FOLD: $8.04 vs. PCVX: $42.39)
Brand notoriety: FOLD and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 64% vs. PCVX: 78%
Market capitalization -- FOLD: $2.48B vs. PCVX: $5.5B
FOLD [@Biotechnology] is valued at $2.48B. PCVX’s [@Biotechnology] market capitalization is $5.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 4 TA indicator(s) are bullish while PCVX’s TA Score has 5 bullish TA indicator(s).

  • FOLD’s TA Score: 4 bullish, 5 bearish.
  • PCVX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than FOLD.

Price Growth

FOLD (@Biotechnology) experienced а -3.13% price change this week, while PCVX (@Biotechnology) price change was -3.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

FOLD is expected to report earnings on Nov 05, 2025.

PCVX is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($5.5B) has a higher market cap than FOLD($2.48B). FOLD YTD gains are higher at: -14.650 vs. PCVX (-48.216). FOLD has higher annual earnings (EBITDA): 33.1M vs. PCVX (-584.35M). PCVX has more cash in the bank: 1.66B vs. FOLD (231M). PCVX has less debt than FOLD: PCVX (85.8M) vs FOLD (443M). FOLD has higher revenues than PCVX: FOLD (571M) vs PCVX (0).
FOLDPCVXFOLD / PCVX
Capitalization2.48B5.5B45%
EBITDA33.1M-584.35M-6%
Gain YTD-14.650-48.21630%
P/E RatioN/AN/A-
Revenue571M0-
Total Cash231M1.66B14%
Total Debt443M85.8M516%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FOLDPCVX
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 9 days ago
70%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFDVX23.150.05
+0.22%
Applied Finance Explorer Investor
QISOX13.42N/A
N/A
Pear Tree Polaris Intl Opps Ord
RIVGX20.44N/A
N/A
American Funds International Vntg R-6
UUOAX21.14N/A
N/A
GMO U.S. Opportunistic Value Vi
TIBIX32.32-0.14
-0.43%
Thornburg Investment Income Builder I